The Traderszone Network

Published in TZ Latest News 2 December, 2016 by The TZ Newswire Staff

Aradigm Lung Infection Antibiotic Fails Trial (ARDM)

Aradigm reported mixed study results for its inhaled antibiotic for lung disease.